Why Developed Countries Struggle With Cataract Waiting Times — The NHS as a Case Study
Picture this: you're 65, your GP has just told you that you have cataracts in both eyes, and you've been referred for surgery. The operation takes about 20 minutes. It's one of the most commonly performed procedures in the world. And yet — you're looking at a wait that could stretch well past a year.
A Shared Challenge Across Developed Nations
This isn't just a UK story. It's an OECD story. OECD Health at a Glance 2023 shows cataract surgery among the elective procedures with the steepest post-pandemic wait growth across member nations. Three forces are driving this — and none of them are going away soon.
Demographics come first. Cataracts are strongly age-related, with prevalence rising sharply after 60. As populations age across every OECD country, demand for cataract surgery grows faster than public systems were built to handle.
Budget pressure is the second force. Elective procedures get pushed back when emergency care demand rises. Cataract surgery — despite its real impact on daily life — sits in the elective category. When budgets are tight, it waits.
Specialist shortages complete the picture. Ophthalmology training pipelines are long. The OECD Health Workforce report identifies specialist shortages as one of the most persistent structural problems in elective care. You can't train a surgeon in six months.
Longer waits. More countries. More patients.
Inside the NHS Case
The NHS offers the most thoroughly documented version of this problem — which makes it useful for patients across the English-speaking world, not just the UK.
Before COVID-19, most cataract patients were treated within 18 weeks — in line with the NHS constitutional standard. Then the pandemic suspended elective surgery from March to July 2020. The backlog that built up didn't clear quickly. By 2022, over 400,000 patients were waiting for ophthalmology treatment, according to NHS England's Referral to Treatment (RTT) statistics. By 2024, ophthalmology remained one of the largest NHS waiting lists despite recovery efforts.
The national average hides a lot. NHS England's regional data shows some regions waiting more than twice the national average. A patient in one part of England might get surgery within four months. Another, in a different region, might wait over a year for the same procedure. Same condition. Same NHS. Very different experience.
What does the NHS say about it? NHS England's own analysis points to theatre capacity constraints, ophthalmologist shortages, and the difficulty of managing new referrals on top of an existing backlog. The NHS Long Term Workforce Plan (2023) names ophthalmology as one of the specialties most constrained relative to projected demand.
None of this is a quality problem. It's a capacity problem — one the NHS has documented and is actively working to address.
The Same Pressure, Other Developed Nations
The NHS case is instructive precisely because it isn't unique.
Australia's public system faces similar pressure. The Australian Institute of Health and Welfare consistently lists cataract surgery among the longest-wait elective procedures. Access varies significantly by state — some patients wait well beyond the clinically recommended timeframe, according to the Australian Government Department of Health.
Across the Tasman, New Zealand tells a similar story. Health New Zealand (Te Whatu Ora) shows ophthalmology demand consistently exceeding funded capacity. Some patients wait over 12 months for publicly funded cataract surgery.
Canada sits in the same picture — though its provincial structure means wait times vary widely. The OECD Health Statistics database places the country among nations with above-average elective wait times — driven by the same combination of ageing population, provincial budget constraints, and specialist gaps.
The pattern is the same everywhere. Universal or near-universal coverage, finite resources, growing demand. Cataract surgery sits at the intersection of all three pressures — and that's not changing soon.
What About RLE? NHS Does Not Cover Lens Replacement for Refractive Correction
Before we get to your options, one clarification matters — because the same surgical procedure sits inside two very different funding worlds.
The NHS covers cataract surgery because cataracts are a pathological condition: a clouded natural lens that materially affects vision. Refractive Lens Exchange (RLE) — the same procedure used electively to correct presbyopia, high myopia, or hyperopia in eyes without cataracts — is not covered. RLE is classed as an elective refractive procedure, the same category as LASIK.
This matters even for patients with cataracts. If you want a premium multifocal or extended-depth-of-focus IOL to reduce your dependence on glasses, the NHS will typically only fund a standard monofocal lens. Any upgrade is out-of-pocket, and the price gap can run into the thousands per eye.
For people without cataracts who want lens-based vision correction, RLE in the UK is a 100% private-pay market — a different problem from the cataract waiting-list pressure described above, but worth naming, because patients often discover the distinction only after they've started asking questions. If RLE is what you're actually weighing, our analysis of the trade-offs of lens replacement surgery covers the considerations specific to that pathway.
Four Options for Patients
So what can you actually do?
If you or a family member is on a public waiting list, there are four main pathways — each with real trade-offs worth understanding.
Option 1: Stay on the public list. For many people, this is still the right call — particularly where vision impairment is mild, the wait is months not years, and there are no safety concerns like driving or fall risk.
While you're waiting: ask your GP for a written visual acuity baseline. Request re-prioritisation if your vision gets significantly worse before your surgery date. Check your driving licence status — in the UK, the DVLA standard requires reading a number plate at 20 metres. And keep your referral active; missed contacts can remove you from the list in some systems.
Option 2: Public-to-private pathway. In the UK, the NHS Choice Framework sets out when NHS patients can choose a private provider for NHS-funded treatment. Self-funding private treatment bypasses the waiting list entirely — typically two to four weeks. UK private cataract surgery runs £2,000–£3,500 per eye depending on IOL type and provider. Nuffield Health and Spire Healthcare publish indicative pricing. In Australia, private health insurance with hospital cover typically includes cataract surgery — the Private Health Insurance Ombudsman covers what's included.
Option 3: Local private, self-funded. For people without insurance who want a predictable timeline, indicative costs are:
- UK: £2,000–£3,500 per eye (standard monofocal IOL; premium multifocal IOLs higher)
- Australia: AUD 2,500–4,500 per eye (out-of-pocket after Medicare rebate)
- New Zealand: NZD 2,500–4,000 per eye
Always ask for a detailed quote specifying what's included — pre-operative assessment, IOL type, follow-up consultations. Prices vary more than you'd expect.
Option 4: International options. Medical travel for cataract surgery has grown significantly over the past decade. But the destinations aren't interchangeable — each has a different profile.
Turkey is one of the most popular destinations for UK and European patients. Istanbul is roughly four hours by direct flight from London, and several hospitals hold JCI accreditation — the internationally recognised quality standard. Costs are substantially lower than UK private rates.
Hungary has a well-established medical tourism infrastructure, particularly for EU and UK patients. Budapest has multiple ophthalmology clinics with English-speaking staff. UK citizens travel visa-free for short stays post-Brexit.
Thailand has a long-established international healthcare sector. Hospitals like Bumrungrad International in Bangkok hold JCI accreditation and have dedicated international patient services — a common choice for patients from Australia and New Zealand who want to combine treatment with recovery in a leisure destination.
China is increasingly chosen for cataract care. Top-tier ophthalmology hospitals are known for high surgeon case volumes — leading specialists at major centres perform several thousand procedures annually. Modern phacoemulsification equipment and JCI-accredited facilities are standard at these hospitals. Costs are typically a fraction of UK or Australian private rates. It's worth researching specific hospitals and their international patient services directly before making any plans.
Every international destination involves real trade-offs: travel logistics, follow-up care, language, and managing any post-operative complications from a distance. These deserve careful thought before you commit.
What's the Right Call for You?
No single answer fits everyone. The right pathway depends on four things specific to your situation:
| Factor | Lean toward waiting | Lean toward alternatives |
|---|---|---|
| Wait tolerance | Months, not years | Already 12+ months, no end date |
| Budget | Limited flexibility | Can self-fund or have insurance |
| Vision impact | Mild impairment, stable | Affecting driving, work, or safety |
| Travel ability | Limited mobility or health constraints | Fit to travel, support available |
If your vision is stable and the wait is measured in months, staying on the public list is entirely reasonable. But if you're past 12 months and your vision is affecting daily life — understanding your alternatives is a practical step, not a drastic one.
For patients interested in the international option in more depth, our guide to cataract surgery in China covers the clinical landscape, hospital accreditation, and what to expect as an international patient.
And if you're still on a public waiting list — what has your GP actually told you about your options?
This article is general patient information, not a clinical recommendation for any individual. Waiting times, prices and policies change; always confirm current figures directly with the relevant health authority, clinic or hospital before making a decision, and discuss any planned surgery with a registered ophthalmologist in your home country. MediConnex coordinates information and logistics for patients exploring international care and does not provide medical advice — see our medical disclaimer for the full position, or return to the homepage to get in touch.